Back to top

immuno-therapy: Archive

Sanghamitra Saha

Is Healthcare Losing the Status of Safe Haven? ETFs in Focus

Healthcare stocks face new risks under Trump, despite their usual defensive reputation.

PFEPositive Net Change SPYNegative Net Change XLVPositive Net Change XHSPositive Net Change IHENegative Net Change MEDPPositive Net Change IDNAPositive Net Change

Zacks Equity Research

AstraZeneca's Imfinzi Gets FDA Nod for Bladder Cancer Indication

The FDA approves AZN's sBLA seeking the expanded use of Imfinzi for adult patients with muscle-invasive bladder cancer.

AZNPositive Net Change DVAXPositive Net Change BAYRYPositive Net Change CORTPositive Net Change